NZ526792A - Film coating composition for controlled release from pharmaceutical formulations - Google Patents

Film coating composition for controlled release from pharmaceutical formulations

Info

Publication number
NZ526792A
NZ526792A NZ526792A NZ52679202A NZ526792A NZ 526792 A NZ526792 A NZ 526792A NZ 526792 A NZ526792 A NZ 526792A NZ 52679202 A NZ52679202 A NZ 52679202A NZ 526792 A NZ526792 A NZ 526792A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical formulations
controlled release
coating composition
film coating
ethylacrylate
Prior art date
Application number
NZ526792A
Other languages
English (en)
Inventor
Arne Hoelzer
Jan-Erik Loefroth
Staffan Schantz
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NZ526792A publication Critical patent/NZ526792A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
  • Laminated Bodies (AREA)
NZ526792A 2001-01-24 2002-01-22 Film coating composition for controlled release from pharmaceutical formulations NZ526792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100200A SE0100200D0 (sv) 2001-01-24 2001-01-24 New film coating
PCT/SE2002/000103 WO2002058677A1 (en) 2001-01-24 2002-01-22 New film coating

Publications (1)

Publication Number Publication Date
NZ526792A true NZ526792A (en) 2004-12-24

Family

ID=20282714

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ526792A NZ526792A (en) 2001-01-24 2002-01-22 Film coating composition for controlled release from pharmaceutical formulations

Country Status (21)

Country Link
US (1) US7959947B2 (enExample)
EP (1) EP1355635B1 (enExample)
JP (1) JP4303471B2 (enExample)
KR (1) KR100874582B1 (enExample)
CN (1) CN1218692C (enExample)
AT (1) ATE285229T1 (enExample)
AU (1) AU2002225573B2 (enExample)
BR (1) BR0206515A (enExample)
CA (1) CA2433530A1 (enExample)
DE (2) DE60202351T2 (enExample)
DK (1) DK1355635T3 (enExample)
ES (1) ES2233804T3 (enExample)
IL (2) IL156623A0 (enExample)
MX (1) MXPA03006419A (enExample)
NO (1) NO20033305L (enExample)
NZ (1) NZ526792A (enExample)
PT (1) PT1355635E (enExample)
SE (1) SE0100200D0 (enExample)
SI (1) SI1355635T1 (enExample)
WO (1) WO2002058677A1 (enExample)
ZA (1) ZA200305457B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
ES2377729T3 (es) * 2002-02-21 2012-03-30 Valeant International (Barbados) Srl Formulaciones de liberación modificada de al menos una forma de tramadol
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
RU2372893C2 (ru) * 2003-10-31 2009-11-20 Хексал Аг Содержащий фармацевтический агент состав с покрытием
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
DE14172396T1 (de) 2004-10-08 2015-01-08 Forward Pharma A/S Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
CN102369000A (zh) * 2009-01-09 2012-03-07 前进制药公司 包含一种或多种富马酸酯的药用组合物
CN109044985A (zh) 2009-01-09 2018-12-21 前进制药知识产权有限公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
EP2844296B1 (en) * 2012-05-02 2019-03-13 Capsugel Belgium NV Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
MX2015010449A (es) 2013-02-13 2015-10-30 Evonik Roehm Gmbh Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
CN105085778B (zh) * 2014-04-22 2018-11-16 广东华润涂料有限公司 用于缓释功能成分的涂料组合物用水性胶乳、其制备方法以及应用
RS62275B1 (sr) * 2015-03-03 2021-09-30 Saniona As Kombinovana formulacija tesofensina i metoprolola
MA45553A (fr) * 2016-06-30 2019-05-08 Beckman Coulter Inc Substrats chimioluminescents
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) * 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
EP0313845A1 (en) 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
JP2558396B2 (ja) 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
SE0100200D0 (sv) 2001-01-24
CN1218692C (zh) 2005-09-14
WO2002058677A1 (en) 2002-08-01
JP4303471B2 (ja) 2009-07-29
ES2233804T3 (es) 2005-06-16
SI1355635T1 (en) 2005-06-30
MXPA03006419A (es) 2003-10-15
CA2433530A1 (en) 2002-08-01
US7959947B2 (en) 2011-06-14
AU2002225573B2 (en) 2006-09-07
DE20220901U1 (de) 2004-06-17
EP1355635A1 (en) 2003-10-29
ATE285229T1 (de) 2005-01-15
KR20030070122A (ko) 2003-08-27
HK1063432A1 (en) 2004-12-31
NO20033305D0 (no) 2003-07-22
DE60202351T2 (de) 2005-12-01
US20040058001A1 (en) 2004-03-25
ZA200305457B (en) 2004-10-15
IL156623A (en) 2007-12-03
BR0206515A (pt) 2004-02-17
IL156623A0 (en) 2004-01-04
DK1355635T3 (da) 2005-03-29
EP1355635B1 (en) 2004-12-22
NO20033305L (no) 2003-07-22
KR100874582B1 (ko) 2008-12-16
JP2004522741A (ja) 2004-07-29
PT1355635E (pt) 2005-04-29
DE60202351D1 (de) 2005-01-27
CN1487828A (zh) 2004-04-07

Similar Documents

Publication Publication Date Title
NZ526792A (en) Film coating composition for controlled release from pharmaceutical formulations
IL156998A0 (en) New film coating
TR200102918T2 (tr) Tarım kimyasalı formülasyonları
WO2000019984A3 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
CA2214100A1 (en) Sustained release formulation containing three different types of polymers
TW200502006A (en) Controlled release preparation
WO2001078725A3 (en) Modified release formulations containing a hypnotic agent
NZ602302A (en) Controlled release formulations of levodopa and uses thereof
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
PT93384A (pt) Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato
ATE344022T1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
ATE259637T1 (de) Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
WO2002072047A3 (de) Kosmetisches oder pharmazeutisches mittel
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
EP1435370A4 (en) COMPOSITION OF COATING MATERIAL
NZ535750A (en) Film coating for controlled release of pharmaceutical drugs
UA93530C2 (ru) Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения
IT1303753B1 (it) Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici.
CA2281474A1 (en) Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof
SE0104327D0 (sv) New film coating
WO2004037226A3 (en) Pharmaceutical compositions containing venlafaxine
KR100469943B1 (ko) 장용성 코팅제로 사용되는 아크릴 공중합체의 제조 방법
DE50009266D1 (de) Festigende Haarreinigungsmittel

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)